CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 501–600 of 1,013
Lúcia, M., Luque, S., Crespo, E., Melilli, E., Cruzado, J. M., Martorell, J., Jarque, M., Gil‐Vernet, S., Manonelles, A., Grinyo, J. M., et al. (2015) · Kidney International · doi:10.1038/ki.2015.205 · Cited by 123
Vabulas, R. M., Pircher, H., Lipford, G. B., Häcker, H., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2372 · Cited by 123
Schaub, A., Fütterer, A., & Pfeffer, K. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3714::aid-immu3714>3.0.co;2-1 · Cited by 144
Inhibition of Coagulation by a Phosphorothioate Oligonucleotide
HENRY, S. P., NOVOTNY, W., LEEDS, J., AULETTA, C., & KORNBRUST, D. J. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.503 · Cited by 123
Liu, H.-M., Newbrough, S. E., Bhatia, S. K., Dahle, C. E., Krieg, A. Μ., & Weiner, G. J. (1998) · Blood · doi:10.1182/blood.v92.10.3730 · Cited by 122
Self-citationShirota, H., Sano, K., Hirasawa, N., Terui, T., Ohuchi, K., Hattori, T., Shirato, K., & Tamura, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.66 · Cited by 122
Serebrisky, D., Teper, A. A., Huang, C.-K., Lee, S., Zhang, T.-F., Schofield, B., Kattan, M., Sampson, H. A., & Li, X. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5906 · Cited by 128
Häcker, H., Mischak, H., Häcker, G., Eser, S., Prenzel, N., Ullrich, A., & Wagner, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.6973 · Cited by 131
Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody
Li, S., Tan, Y., Viroonchatapan, E., Pitt, B. R., & Huang, L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.3.l504 · Cited by 122
Targeting the TLR9–MyD88 pathway in the regulation of adaptive immune responses
Huang, X., & Yang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.501333 · Cited by 121
Comparison of human B cell activation by TLR7 and TLR9 agonists
Hanten, J. A., Vasilakos, J. P., Riter, C. L., Neys, L., Lipson, K. E., Alkan, S. S., & Birmachu, W. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-39 · Cited by 121
Rattanakiat, S., Nishikawa, M., Funabashi, H., Luo, D., & Takakura, Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.053 · Cited by 121
B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides
Jahrsdorfer, B., Mühlenhoff, L., Blackwell, S. E., Wagner, M., Poeck, H., Hartmann, E., Jox, R., Giese, T., Emmerich, B., Endres, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1890 · Cited by 121
Catalytic Nucleic Acids: From Lab to Applications
Sun, L., Cairns, M. J., Saravolac, E. G., Baker, A., & Gerlach, W. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01455-8 · Cited by 142
Dalpke, A. H., Zimmermann, S., Albrecht, I., & Heeg, K. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01410.x · Cited by 119
Ebert, S., Gerber, J., Bader, S., Muehlhauser, F., Brechtel, K., Mitchell, T. J., & Nau, R. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.005 · Cited by 133
Signaling by CD40 and its Mimics in B Cell Activation
Bishop, G. A., & Hostager, B. S. (2001) · Immunologic Research · doi:10.1385/ir:24:2:097 · Cited by 121
Self-citationRoda, J. M., Parihar, R., & Carson, W. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1619 · Cited by 132
Yung, R. L., Chang, S. P., Hemati, N., Johnson, K. J., & Richardson, B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400811 · Cited by 120
Rockwell, P., O’Connor, W. J., King, K. D., Goldstein, N. I., Zhang, L.-M., & Stein, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6523 · Cited by 120
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA
Krieg, A. Μ. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90004-9 · Cited by 120
Self-citationLactobacilli as multifaceted probiotics with poorly disclosed molecular mechanisms
Turpin, W., Humblot, C., Thomas, M., & Guyot, J. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.07.032 · Cited by 141
Targeting dendritic cells—why bother?
Kreutz, M., Tacken, P. J., & Figdor, C. G. (2013) · Blood · doi:10.1182/blood-2012-09-452078 · Cited by 138
Torii, A., Torii, S., Fujiwara, S., Tanaka, H., Inagaki, N., & Nagai, H. (2007) · Allergology International · doi:10.2332/allergolint.o-06-459 · Cited by 119
Wu, S., Liao, C., Lin, Y., Yeh, C., Chen, L., Huang, Y.-F., Chou, H.-Y., Huang, J.-L., Shaio, M., & Sytwu, H. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00310-4 · Cited by 119
Inhibition of HBV replication by siRNA in a stable HBV-producing cell line
Konishi, M., Wu, C. H., & Wu, G. Y. (2003) · Hepatology · doi:10.1002/hep.1840380410 · Cited by 119
CpG DNA is an effective oral adjuvant to protein antigens in mice
McCluskie, M. J., Weeratna, R. D., Krieg, A. Μ., & Davis, H. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00215-2 · Cited by 119
Self-citationAn, H.-Z., Xu, H.-M., Yu, Y.-Z., Zhang, M.-H., Qi, R.-Z., Yan, X., Liu, S.-X., Wang, W.-Y., Guo, Z., Qin, Z.-H., et al. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00010-x · Cited by 133
Sundar, K., Jacques, S., Gottlieb, P., Villars, R., Benito, M.-E., Taylor, D. K., & Spatz, L. A. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.06.001 · Cited by 119
Bacterial DNA as immune cell activator
Lipford, G. B. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01408-5 · Cited by 121
Manickasingham, S. P., Edwards, A. D., Schulz, O., & Sousa, C. R. E. (2002) · European Journal of Immunology · doi:10.1002/immu.200390001 · Cited by 118
Xu, W., Santini, P. A., Matthews, A. J., Chiu, A., Plebani, A., He, B., Chen, K., & Cerutti, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.276 · Cited by 126
Kasuya, T., Hori, S.-I., Watanabe, A., Nakajima, M., Gahara, Y., Rokushima, M., Yanagimoto, T., & Kugimiya, A. (2016) · Scientific Reports · doi:10.1038/srep30377 · Cited by 125
Yoo, B. H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh516 · Cited by 115
DNA vaccine strategies: candidates for immune modulation and immunization regimens
Doria‐Rose, N. A. (2003) · Methods · doi:10.1016/s1046-2023(03)00135-x · Cited by 116
Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides
Kamstrup, S., Verthelyi, D. I., & Klinman, D. M. (2001) · Veterinary Microbiology · doi:10.1016/s0378-1135(00)00300-x · Cited by 116
Self-citationGaudier, E. A., Michel, C., Segain, J., Cherbut, C., & Hoebler, C. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2753 · Cited by 141
Kobayashi, N., Kuramoto, T., Yamaoka, K., Hashida, M., & Takakura, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29608-7 · Cited by 116
Selective uptake and sustained expression of AAV vectors following subcutaneous delivery
Donahue, B. A., McArthur, J. G., Spratt, S. K., Bohl, D., Lagarde, C., Sanchez, L., Kaspar, B., Sloan, B. A., Lee, Y. L., Danos, O., et al. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199901/02)1:1<31::aid-jgm3>3.0.co;2-t · Cited by 49
Self-citationImmune Recognition of Foreign DNA
Klinman, D. M., Verthelyi, D. I., Takeshita, F., & Ishii, K. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80087-4 · Cited by 116
Self-citationMechanism of Action of CpG DNA
KRIEG, A. M., Hartmann, G., & Yi, A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_1 · Cited by 116
Self-citationZhang, H., Chen, W., Gong, K., & Chen, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09583 · Cited by 116
Developments in Vaccine Adjuvants
Firdaus, F. Z., Skwarczyński, M., & Tóth, I. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_8 · Cited by 122
Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA
Singh, M., Ott, G. S., Kazzaz, J., Ugozzoli, M., Briones, M., Donnelly, J., & O’Hagan, D. T. (2001) · Pharmaceutical Research · doi:10.1023/a:1012269226066 · Cited by 115
Endogenous TLR Ligands and Autoimmunity
Wagner, H. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91004-9 · Cited by 124
Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo
Scherer, F., Schillinger, U., Putz, U., Stemberger, A., & Plank, C. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.298 · Cited by 115
Bowersock, T. L., & Martin, S. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00015-0 · Cited by 115
Bhan, U., Lukacs, N. W., Osterholzer, J. J., Newstead, M. W., Zeng, X., Moore, T. A., McMillan, T. R., Krieg, A. Μ., Akira, S., & Standiford, T. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3937 · Cited by 115
Self-citationRegulation of autoreactive B cell responses to endogenous TLR ligands
Avalos, A. M., Busconi, L., & Marshak-Rothstein, A. (2010) · Autoimmunity · doi:10.3109/08916930903374618 · Cited by 114
“One fragment, designated CG50, incorporated 50 canonical CpG motifs that recapitulated the optimal murine TLR9 ligand originally identified through a screen of phosphorothioate-stabilized single-stranded CpG oligodeoxynucleotides [22].”
BackgroundDNA nanotubes as intracellular delivery vehicles in vivo
Sellner, S., Kocabey, S., Nekolla, K., Krombach, F., Liedl, T., & Rehberg, M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.099 · Cited by 116
Kranzer, K., Bauer, M., Lipford, G. B., Heeg, K., Wagner, H., & Lang, R. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00964.x · Cited by 115
Iho, S., Yamamoto, T., Takahashi, T., & Yamamoto, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3642 · Cited by 135
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Flierl, U., Nero, T. L., Lim, B., Arthur, J. F., Yao, Y., Jung, S. M., Gitz, E., Pollitt, A. Y., Zaldivia, M. T. K., Jandrot-Perrus, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140391 · Cited by 114
RNA Mediated toll-like receptor stimulation in health and disease
Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113
Gotoh, K., Tanaka, Y., Nishikimi, A., Nakamura, R., Yamada, H., Maeda, N., Ishikawa, T., Hoshino, K., Uruno, T., Cao, Q., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091776 · Cited by 112
Development of immunoadjuvants for immunotherapy of cancer
Azuma, I., & Seya, T. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00055-8 · Cited by 121
CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection
Verthelyi, D. I., Gürsel, M., Kenney, R. T., Lifson, J. D., Liu, S., Mican, J., & Klinman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4717 · Cited by 113
Self-citationAntisense oligonucleotides: Is the glass half full or half empty?
Bennett, C. F. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00214-1 · Cited by 113
Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112
Kageyama, Y., Kasahara, T., Kato, M., Sakai, S., Deguchi, Y., Tani, M., Kuroda, K., Hattori, K., Yoshida, S., Goto, Y., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.001 · Cited by 110
He, H., Crippen, T. L., Farnell, M. B., & Kogut, M. H. (2003) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(03)00013-2 · Cited by 112
Trouw, L. A., Nilsson, S. C., Gonçalves, I., Landberg, G., & Blom, A. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050189 · Cited by 110
Obermeier, F., Dunger, N., Strauch, U., Hofmann, C., Bleich, A., Grunwald, N., Hedrich, H. J., Aschenbrenner, E., Schlegelberger, B., Rogler, G., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.061 · Cited by 114
Dendritic Cell Modulation by Mast Cells Controls the Th1/Th2 Balance in Responding T Cells
Mazzoni, A., Siraganian, R. P., Leifer, C. A., & Segal, D. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3577 · Cited by 111
Karbach, J., Gnjatic, S., Bender, A., Neumann, A., Weidmann, E., Yuan, J. D., Ferrara, C. A., Hoffmann, E. W., Old, L. J., Altorki, N. K., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24850 · Cited by 111
Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation
Ouyang, X., Negishi, H., Takeda, R., Fujita, Y., Taniguchi, T., & Honda, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.090 · Cited by 124
Stopeck, A., Jones, A., Hersh, E. M., Thompson, J. A., Finucane, D., Gutheil, J. C., & Gonzalez, R. C. (2001) · PubMed · Cited by 111
Gao, J. J., Zuvanich, E. G., Xue, Q., Horn, D. L., Silverstein, R., & Morrison, D. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4095 · Cited by 113
Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Uden, J. H. V., Horner, A. A., Corr, M., & Raz, E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4907 · Cited by 123
Hildebrand, J. M., Yi, Z., Buchta, C. M., Poovassery, J., Stunz, L. L., & Bishop, G. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01055.x · Cited by 110
Self-citationKaji, E. H., & Leiden, J. M. (2001) · JAMA · doi:10.1001/jama.285.5.545 · Cited by 131
Combination adjuvants: the next generation of adjuvants?
Mutwiri, G., Gerdts, V., den Hurk, S. V. D. L., Auray, G., Eng, N. F., Garlapati, S., Babiuk, L. A., & Potter, A. A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.154 · Cited by 123
Reddy, S. M., Hsiao, K.-H. K., Abernethy, V. E., Fan, H., Longacre, A., Lieberthal, W., Rauch, J., Koh, J. S., & Levine, J. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.702 · Cited by 110
Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
Warren, T. L., & Weiner, G. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200005000-00007 · Cited by 112
Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation
Joo, H., Coquery, C. M., Xue, Y., Gayet, I., Dillon, S. R., Punaro, M., Zurawski, G., Banchereau, J., Pascual, V., & Oh, S. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111644 · Cited by 113
Use of minicircle plasmids for gene therapy.
Mayrhofer, P., Schleef, M., & Jechlinger, W. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-561-9_4 · Cited by 125
Kemp, T. J., Moore, J. M., & Griffith, T. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.892 · Cited by 115
The role of CpG motifs in immunostimulation and gene therapy
Scheule, R. K. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00090-9 · Cited by 109
Accessing the therapeutic potential of immunostimulatory nucleic acids
Barchet, W., Wimmenauer, V., Schlee, M., & Hartmann, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.007 · Cited by 129
Xie, H., Gürsel, İ., Ivins, B. E., Singh, M., O’Hagan, D. T., Ulmer, J. B., & Klinman, D. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.828-833.2005 · Cited by 109
Self-citationLenert, P. S., Stunz, L. L., Yi, A., Krieg, A. Μ., & Ashman, R. F. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001317022241 · Cited by 109
Self-citationWalker, P., Scharton‐Kersten, T., ROWTON, E. D., Hengge, U. R., Bouloc, A., Udey, M. C., & Vogel, J. C. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1899 · Cited by 109
Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
Gilkeson, G. S., Ruiz, P., Pippen, A. M., Alexander, A. L., Lefkowith, J. B., & Pisetsky, D. S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1389 · Cited by 109
Targeting pattern recognition receptors in cancer immunotherapy
Goutagny, N., Estornes, Y., Hasan, U. A., Lebecque, S., & Caux, C. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0213-1 · Cited by 121
RETRACTED: Dendrimer nanocarriers as versatile vectors in gene delivery
Dutta, T., Jain, N. K., McMillan, N. A. J., & Parekh, H. S. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.05.005 · Cited by 116
RetractedUnderstanding GroEL and DnaK Stress Response Proteins as Antigens for Bacterial Diseases
Fourie, K. R., & Wilson, H. L. (2020) · Vaccines · doi:10.3390/vaccines8040773 · Cited by 127
Particle size and activation threshold: a new dimension of danger signaling
Rettig, L., Haen, S. P., Bittermann, A. G., von Boehmer, L., Curioni, A., Krämer, S. D., Knuth, A., & Pascolo, S. (2010) · Blood · doi:10.1182/blood-2009-11-247817 · Cited by 108
Siegrist, C., Pihlgren, M., Tougne, C., Efler, S. M., Morris, M. L., Al-Adhami, M., Cameron, D. W., Cooper, C., Heathcote, J., Davis, H. L., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.014 · Cited by 108
Effect of Suppressive DNA on CpG-Induced Immune Activation
Yamada, H., Gürsel, İ., Takeshita, F., Conover, J., Ishii, K. J., Gürsel, M., Takeshita, S., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5590 · Cited by 109
Self-citationIn vivo manipulation of dendritic cells to induce therapeutic immunity
Merad, M., Sugie, T., Engleman, E. G., & Fong, L. (2002) · Blood · doi:10.1182/blood.v99.5.1676 · Cited by 109
Heeg, K. M., & Zimmermann, S. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024303 · Cited by 111
Pyles, R. B., Higgins, D., Chalk, C., Zalar, A., Eiden, J., Brown, C., Nest, G. V., & Stanberry, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11387-11396.2002 · Cited by 108
Nucleic Acid–Based Functional Nanomaterials as Advanced Cancer Therapeutics
Yuan, Y., Gu, Z., Yao, C., Luo, D., & Yang, D. (2019) · Small · doi:10.1002/smll.201900172 · Cited by 113
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update
Lee, G. H., & Lim, S. G. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1908133 · Cited by 119
Nakamura, K., Miyazato, A., Xiao, G., Hatta, M., Inden, K., Aoyagi, T., Shiratori, K., Takeda, K., Akira, S., Saijo, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4067 · Cited by 109
Pepperl‐Klindworth, S., Münster, J., Mach, M., Harris, J. R., & Plachter, B. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6132-6146.2000 · Cited by 126
Yeo, S.-J., Yoon, J.-G., Hong, S., & Yi, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.1052 · Cited by 107
Self-citationKlasa, R. J., Bally, M. B., Ng, R. A., Goldie, J. H., Gascoyne, R. D., & Wong, F. M. (2000) · PubMed · Cited by 107
Wolbachia bacteria in filarial immunity and disease
Taylor, M. J., Cross, H. F., Ford, L., Makunde, W. H., Prasad, G. B. K. S., & Bilo, K. (2001) · Parasite Immunology · doi:10.1046/j.1365-3024.2001.00400.x · Cited by 106
Mechanisms controlling nucleic acid-sensing Toll-like receptors
Miyake, K., Shibata, T., Ohto, U., Shimizu, T., Saitoh, S.-I., Fukui, R., & Murakami, Y. (2018) · International Immunology · doi:10.1093/intimm/dxy016 · Cited by 111
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.